Better Choice CO Inc. BTTR
We take great care to ensure that the data presented and summarized in this overview for Better Choice Co Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding BTTR
View all-
Must Asset Management Inc.1.41MShares$2.62 Million0.46% of portfolio
-
Invenire Partners, LP Ridgefield, CT879KShares$1.64 Million100.0% of portfolio
-
Bergan Kdv Wealth Management, LLC15KShares$27,9000.0% of portfolio
-
Nbt Bank N A114Shares$2120.0% of portfolio
-
Future Financial Wealth Managment LLC12Shares$220.0% of portfolio
Latest Institutional Activity in BTTR
Top Purchases
Top Sells
About BTTR
Better Choice Company Inc. operates as an animal health and wellness company. Its products portfolio includes naturally formulated kibble and canned dog and cat foods, freeze-dried raw dog foods and treats, vegan dog foods and treats, oral care products and supplements, as well as toppers, dental products, chews, and grooming products. The company provides its products for dogs, cats, and pet parents under the Halo and TruDog brand names. Better Choice Company Inc. primarily sells its products through its online portals, as well as through online retailers and pet specialty stores. It has operations in the United States, Canada, China, and Asia. The company was formerly known as Sports Endurance, Inc. and changed its name to Better Choice Company Inc. in March 11, 2019. Better Choice Company Inc. was founded in 1986 and is based in Tampa, Florida.
Insider Transactions at BTTR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 01
2024
|
Arlene Dickinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
370,370
+38.46%
|
$0
$0.27 P/Share
|
Feb 01
2024
|
Michael Young Director |
BUY
Grant, award, or other acquisition
|
Direct |
370,370
+15.5%
|
$0
$0.27 P/Share
|
Feb 01
2024
|
Lionel F. Conacher Director |
BUY
Grant, award, or other acquisition
|
Direct |
370,370
+20.71%
|
$0
$0.27 P/Share
|
Feb 01
2024
|
John M Word Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
370,370
+8.83%
|
$0
$0.27 P/Share
|
Feb 01
2024
|
Gil Fronzaglia Director |
BUY
Grant, award, or other acquisition
|
Direct |
370,370
+38.26%
|
$0
$0.27 P/Share
|
Sep 07
2023
|
Michael Young Director |
BUY
Open market or private purchase
|
Indirect |
40,000
+8.53%
|
$0
$0.13 P/Share
|
Sep 05
2023
|
Michael Young Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+31.26%
|
-
|
Sep 05
2023
|
Lionel F. Conacher Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+41.3%
|
-
|
Jan 31
2023
|
Lionel F. Conacher Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,021
+5.4%
|
-
|
Jan 11
2023
|
Donald Young Chief Sales Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+3.28%
|
-
|
Jan 11
2023
|
Robert Sauermann COO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+36.76%
|
-
|
Jan 11
2023
|
Sharla A Cook CFO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+46.24%
|
-
|
Jan 04
2023
|
Arlene Dickinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
357,144
+44.55%
|
$0
$0.56 P/Share
|
Jan 04
2023
|
John M Word Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
357,144
+4.91%
|
$0
$0.56 P/Share
|
Jan 04
2023
|
Gil Fronzaglia Director |
BUY
Grant, award, or other acquisition
|
Direct |
357,144
+44.0%
|
$0
$0.56 P/Share
|
Jan 04
2023
|
Lionel F. Conacher Director |
BUY
Grant, award, or other acquisition
|
Direct |
178,572
+37.49%
|
$0
$0.56 P/Share
|
Jan 04
2023
|
Michael Young Director |
BUY
Grant, award, or other acquisition
|
Direct |
178,572
+16.57%
|
$0
$0.56 P/Share
|
Dec 30
2022
|
Lionel F. Conacher Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,738
+17.18%
|
$0
$0.54 P/Share
|
Nov 02
2022
|
Lionel F. Conacher Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,817
+30.17%
|
$0
$0.98 P/Share
|
Sep 07
2022
|
Donald Young Chief Sales Officer |
BUY
Open market or private purchase
|
Direct |
11,000
+1.89%
|
$11,000
$1.5 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 1.85M shares |
---|